Murae Organisor Ltd (542724) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 542724 | NSE: | Pharmaceuticals & Drugs | Small Cap

Murae Organisor Share Price

0.27 0.00 0.00%
as on 05-Dec'25 12:17

Murae Organisor Ltd (542724) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 542724 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Murae Organisor

Based on:

M-Cap below 100cr DeciZen not available

Murae Organisor stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
3.63
Market Cap:
55.2 Cr.
52-wk low:
0.3
52-wk high:
1.1

Is Murae Organisor Ltd an attractive stock to invest in?

1. Is Murae Organisor Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Murae Organisor Ltd is a average quality company.

2. Is Murae Organisor Ltd undervalued or overvalued?

The key valuation ratios of Murae Organisor Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Murae Organisor Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Murae Organisor Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Murae Organisor:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Murae Organisor Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 17.1%22%24.9%24%17.4%4.2%12.3%11.7%0.8%4.2%-
Value Creation
Index
0.20.60.80.70.2-0.7-0.1-0.2-0.9-0.7-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 18.623.335.450.755.141.121153.2855859
Sales YoY Gr.-25.7%51.8%43.1%8.7%-25.5%-48.8%-28.9%-78.6%26,613.1%-
Adj EPS 000.10.20.100.10.1000.1
YoY Gr.-33.3%100%87.5%-26.7%-90.9%1300%-14.3%-100%NA-
BVPS (₹) 0.30.40.40.50.90.911.1111.2
Adj Net
Profit
0.10.10.91.71.80.12.220.17.514
Cash Flow from Ops. -0.30.1-7.1-0.5-3.5-7.12.60.3-15.9-323-
Debt/CF from Ops. -7.224.1-1-20-2.7-1.63.433.3-0-0.7-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 53%73%243.8%26613.1%
Adj EPS 3.3%-18.3%-34.1%NA
BVPS13%3%0%2%
Share Price - -39.4% -34.5% -70.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
7.49.92830.817.90.614.311.20.15.76.5
Op. Profit
Mgn %
2.81.74.46.52.3-18.9-2111.9-14.51.21.2
Net Profit
Mgn %
0.60.62.53.33.30.210.613.31.70.91.7
Debt to
Equity
1.41.41.71.60.60.80.50.5011
Working Cap
Days
01491551511822644796877,764152241
Cash Conv.
Cycle
07189961122054435922,59916222

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 6.50%

Sales growth is growing at healthy rate in last 3 years 243.78%

Sales growth is good in last 4 quarters at 20866.66%

Net Profit has been subdued in last 3 years -34.14%

Latest Financials - Murae Organisor Ltd.

Standalone Consolidated
TTM EPS (₹) 0.1 -
TTM Sales (₹ Cr.) 859 -
BVPS (₹.) 1.2 -
Reserves (₹ Cr.) 30 -
P/BV 0.24 -
PE 3.63 -
From the Market
52 Week Low / High (₹) 0.26 / 1.12
All Time Low / High (₹) 0.26 / 9.91
Market Cap (₹ Cr.) 55.2
Equity (₹ Cr.) 204.5
Face Value (₹) 1
Industry PE 40.7

Management X-Ray of Murae Organisor:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Murae Organisor - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Murae Organisor

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales18.5723.3435.4450.7055.1141.0821.0414.953.20854.82
Operating Expenses 18.0522.9433.8847.4053.8748.8425.4613.173.67844.78
Manufacturing Costs0.050.090.090.100.330.020.030.120.010
Material Costs16.9122.0133.1846.2250.3646.2725.0412.223.09841.30
Employee Cost 0.400.300.100.190.300.290.040.080.050.47
Other Costs 0.680.540.520.892.882.250.350.750.533.02
Operating Profit 0.520.401.553.301.24-7.76-4.421.78-0.4610.04
Operating Profit Margin (%) 2.8%1.7%4.4%6.5%2.2%-18.9%-21.0%11.9%-14.5%1.2%
Other Income 0.060.380.430.052.278.937.701.410.860
Interest 0.400.520.721.040.970.930.080.290.260
Depreciation 0.020.020.020.040.100.120.120.100.060
Exceptional Items 0000000000
Profit Before Tax 0.160.241.242.282.450.123.082.800.0710.03
Tax 0.060.080.330.620.630.030.860.810.022.51
Profit After Tax 0.100.160.911.661.820.092.221.980.057.52
PAT Margin (%) 0.5%0.7%2.6%3.3%3.3%0.2%10.6%13.3%1.7%0.9%
Adjusted EPS (₹)0.00.00.10.10.10.00.10.10.00.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 1.371.534.385.9414.4114.5016.7318.7155.85208.46
Share Capital 0.110.110.310.316.176.1712.3412.3449.42185.90
Reserves 1.261.424.085.648.258.334.396.376.4222.57
Minority Interest0000000000
Debt1.902.066.538.338.4411.338.748.740.01212.75
Long Term Debt0.390.561.492.591.372.38000212.75
Short Term Debt1.511.505.045.747.078.958.748.740.010
Trade Payables4.974.997.016.8211.511.291.21-0.930.06195.02
Others Liabilities 0.552.511.592.161.800.742.122.0763.9535.72
Total Liabilities 8.7911.0819.5123.2636.1627.8728.7928.58119.86651.96

Fixed Assets

Gross Block0.190.210.260.5811.020.950.9500.01
Accumulated Depreciation0.020.050.070.110.210.260.370.4800
Net Fixed Assets 0.170.160.200.480.800.760.580.4800
CWIP 0000000000
Investments 00003.0300000
Inventories3.616.548.2910.9313.3915.4612.2513.1312.181.58
Trade Receivables4.453.5810.7910.8516.9510.6715.048.3910.74252.19
Cash Equivalents 0.360.180.020.160.030.060.050.0311.7146.57
Others Assets 0.200.620.210.841.960.910.876.5685.23351.61
Total Assets 8.7911.0819.5123.2636.1627.8728.7928.58119.86651.96

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -0.260.09-7.09-0.48-3.45-7.102.610.26-15.92-322.97
PBT 0.160.241.242.282.450.123.082.800.0710.03
Adjustment 0.410.430.011.081.071.050.200.390.320.01
Changes in Working Capital -0.77-0.51-8.02-2.18-5.36-7.310.18-2.11-17.13-333.01
Tax Paid -0.06-0.08-0.32-0.62-0.63-0.03-0.86-0.810.810
Cash Flow From Investing Activity -0.15-0.02-0.05-0.32-3.452.940.060-0.48-0.01
Capex -0.15-0.02-0.06-0.32-0.42-0.090.060-0.48-0.01
Net Investments 000.010-3.0300000
Others 000003.030000
Cash Flow From Financing Activity 0.77-0.256.980.946.762.90-2.67-0.2928.08357.83
Net Proceeds from Shares 0.4001.93-0.106.6500037.09145.10
Net Proceeds from Borrowing 0.750.170.970.87-1.221.01-2.3800212.75
Interest Paid -0.38-0.410000-0.08-0.29-0.26-0
Dividend Paid 0000000000
Others -0-0.014.070.171.331.89-0.210-8.74-0.01
Net Cash Flow 0.35-0.18-0.160.14-0.14-1.26-0.01-0.0311.6934.86

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)7.1511.0530.9432.1717.830.6114.2411.180.145.69
ROCE (%)17.121.9724.9423.9917.44.2312.3411.660.814.21
Asset Turnover Ratio2.112.352.322.371.861.280.740.520.042.22
PAT to CFO Conversion(x)-2.60.56-7.79-0.29-1.9-78.891.180.13-318.4-42.95
Working Capital Days
Receivable Days88637478921232232861,09056
Inventory Days71797669811282403101,4433
Payable Days1078366556651184-5242

Murae Organisor Ltd Stock News

Murae Organisor Ltd FAQs

The current trading price of Murae Organisor on 05-Dec-2025 12:17 is ₹0.27.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Murae Organisor stood at ₹55.21.
The latest P/E ratio of Murae Organisor as of 04-Dec-2025 is 3.63.
The latest P/B ratio of Murae Organisor as of 04-Dec-2025 is 0.24.
The 52-week high of Murae Organisor is ₹1.12 and the 52-week low is ₹0.26.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Murae Organisor is ₹858.6 ( Cr.) .

About Murae Organisor Ltd

Earum Pharmaceuticals

Earum Pharmaceuticals was originally incorporated as 'Earum Pharmaceuticals Private Limited' on July 26, 2012 vide Registration no. 071299 under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Further, pursuant to Special Resolution passed by the shareholders at the Extra Ordinary General Meeting held on January 10, 2019, the company was converted into a Public Limited Company and consequently the name of the Company was changed from 'Earum Pharmaceuticals Private Limited' to 'Earum Pharmaceuticals Limited' vide a fresh Certificate of Incorporation dated January 23, 2019 issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of the Company post conversion.

Business area of the company

The company is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections.  Apart from pharmaceutical formulation products, it also deals in trading of active pharmaceutical ingredients (API’s) such as Levofloxacin Hemihdrate IP, Albendazol IP, Amoxicillin Trihydrate IP etc.

Milestones:
2012: Incorporation of the Company in the name of 'Earum Pharmaceuticals Private Limited'.
2014-15: Total turnover of the Company reached to Rs. 8 crores.
2015-16: Crossed Turnover of Rs. 18 crores.
2016-17: Crossed Turnover of Rs. 23 crores.
2017-18: Crossed Turnover of Rs. 35 crores.
2019: Conversion of the Company from Private Limited to Public Limited Company.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×